Delphine Lebon

<i>IDH1/2</i>but not<i>DNMT3A</i>mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

Houria Debarri, Delphine Lebon, Christophe Roumier et al. · Oncotarget · 2015 · 97 citations · Full text

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Raphaël Itzykson, Élise Fournier, Céline Berthon et al. · Blood · 2021 · 61 citations · Full text

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells

Alexis Caulier, Nicolas Jankovsky, Yohann Demont et al. · Haematologica · 2019 · 57 citations · Full text

A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia

Laurène Fenwarth, Xavier Thomas, Stéphane de Botton et al. · Blood · 2020 · 50 citations · Full text

Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics

Delphine Lebon, François Vergez, Sarah Bertoli et al. · Leukemia Research · 2015 · 36 citations

Younger Aml Patients, Urology, Autoimmune Disease +6